A clinical trial update wiped out billions in the French company's market cap and raised questions over a potential takeover.

Abivax said its experimental treatment for ulcerative colitis showed significant efficacy in a closely watched trial, but ...

Shares in French biotech Abivax tumbled more than 30% today, after it announced phase 3 data with ulcerative colitis (UC) ...

Abivax stock plummeted Tuesday after several patients developed cancer following a study of its ulcerative colitis treatment.

Jefferies downgraded the French biotech to Hold and cut its price target nearly in half, warning the cancer overhang won't ...

Abivax (ABVX) plunged in premarket trading on Tuesday despite announcing positive Phase 3 maintenance trial results for its ...

Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis At Week 44, both the 25 mg and 50 mg once-daily obefazimod ...

Our gut is the key to much of our body's overall health, which is why diseases like ulcerative colitis can be so detrimental. Ulcerative colitis is one of the most common inflammatory bowel diseases.

Ulcerative colitis (UC) is a type of inflammatory bowel disease (IBD). It causes painful sores and inflammation deep inside your colon and rectum. That can lead to hard-to-manage symptoms like ...

If you’re looking for more information about ulcerative colitis, here are some sources that can help. Nonprofit organizations can provide background materials on topics like treatment, nutrition, and ...